| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/05/2002 | CA2078006C Multichromophore fluorescent probes |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | WO2002008223A1 Indole derivatives useful for the treatment of cns disorders |
| 01/31/2002 | WO2002008221A2 Capsaicin receptor ligands |
| 01/31/2002 | WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 01/31/2002 | WO2002008216A1 Novel compounds and their use as glycine transport inhibitors |
| 01/31/2002 | WO2002008207A1 Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine |
| 01/31/2002 | WO2002008205A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 01/31/2002 | WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 01/31/2002 | WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | WO2001070737A3 Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof |
| 01/31/2002 | US20020013472 Oxyranyle-triazoline thiones and their use as microbicides |
| 01/31/2002 | US20020013460 Condensed pyridine compound |
| 01/31/2002 | US20020013360 Protease inhibitors |
| 01/31/2002 | US20020013349 Administering drug which opens potassium channel for reducing pain |
| 01/31/2002 | US20020013346 C7 ester substituted taxanes |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013318 Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 01/31/2002 | US20020013317 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease |
| 01/31/2002 | US20020012977 Enzymatic oxidations |
| 01/31/2002 | DE10035038A1 Substituierte 2-Amino-1,3,5-triazine, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren Substituted 2-amino-1,3,5-triazines, to processes for preparation and use as herbicides and plant growth regulators |
| 01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
| 01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | CA2416447A1 Novel compounds and their use as glycine transport inhibitors |
| 01/31/2002 | CA2415740A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | CA2415606A1 Capsaicin receptor ligands |
| 01/30/2002 | EP1176144A1 N-triazolylmethyl-piperazine derivatives as neurokinine receptor-antagonists |
| 01/30/2002 | EP1176140A1 Amide compounds and medicinal use thereof |
| 01/30/2002 | EP1176134A1 Ligands of nuclear receptors ppar's |
| 01/30/2002 | EP1175416A1 Heteroaryl diazacycloalkanes, their preparation and use |
| 01/30/2002 | EP1175414A1 Taxane formulations having improved solubility |
| 01/30/2002 | EP1175410A1 Pesticidal triazine derivatives |
| 01/30/2002 | EP1175409A1 Pyrimidinones derivatives for the treatment of atherosclerosis |
| 01/30/2002 | EP1175406A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
| 01/30/2002 | EP1175402A1 Piperidine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175401A1 Piperazine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175399A1 Inhibitors of c-jun n-terminal kinases (jnk) |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP1175397A1 3,3-substituted indoline derivatives |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/30/2002 | EP0922043B1 Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles |
| 01/30/2002 | EP0866791B1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | CN1333770A Novel dicyclic compound |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333767A Aromatic heterocyclic compounds as antiinflammatory agent |
| 01/30/2002 | CN1333764A Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333755A Benzimidazole compounds that are vitronectin receptor antagonists |
| 01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
| 01/30/2002 | CN1333751A Substituted pyridine Herbicides |
| 01/30/2002 | CN1333018A Medicine for treating immune relative disease of anterior chamber and surface of eye |
| 01/29/2002 | US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating |
| 01/29/2002 | US6342516 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 01/29/2002 | US6342511 Racemic, enantiomorphs and diasteriomorphs |
| 01/29/2002 | US6342505 Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1 |
| 01/29/2002 | US6342503 Antidepressants, eating disorders |
| 01/29/2002 | US6342245 Compositions of lipid lowering agents |
| 01/29/2002 | CA2165996C Stereoselective preparation of 2-substituted succinic derivatives |
| 01/29/2002 | CA2048347C Process for the preparation of deoxynucleosides |
| 01/24/2002 | WO2002006276A1 Beta3 adrenergic agonists |
| 01/24/2002 | WO2002006275A1 Novel processes for the preparation of 4-phenylpiperidine derivatives |
| 01/24/2002 | WO2002006273A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 01/24/2002 | WO2002006272A1 Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof |
| 01/24/2002 | WO2002006270A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | WO2002006264A1 Lipid-rich plaque inhibitors |
| 01/24/2002 | WO2002006254A1 Tetrazole derivatives |
| 01/24/2002 | WO2002006252A1 Asymmetric dihydrotriazines as pesticides |
| 01/24/2002 | WO2002006251A1 Substituted 2-amino-1,3,5-triazines, and the use thereof as herbicides and plant growth regulators |
| 01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | WO2002006246A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | WO2002006234A1 Sulfone derivatives, process for their production and use thereof |
| 01/24/2002 | WO2002006232A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006231A1 Serotonin reuptake inhibitors |
| 01/24/2002 | WO2002006224A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 01/24/2002 | WO2002006223A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 01/24/2002 | WO2002006221A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2001058875A3 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010190 N-heterocyclic derivatives as NOS inhibitors |
| 01/24/2002 | US20020010186 Dihydropyrimidines and uses thereof |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020010181 Angiogenesis inhibitors as antitumor agents |
| 01/24/2002 | US20020010169 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | CA2429008A1 Lipid-rich plaque regressing agents |
| 01/24/2002 | CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | CA2416667A1 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416384A1 Sulfone derivatives, their production and use |
| 01/24/2002 | CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | CA2415935A1 Novel 6-heteroarylphenanthridines |